Selective laser sintering (SLS) technique for pharmaceutical applications-Development of high dose controlled release printlets

The paper presents the unique approach to 3D printing by Selective Laser Sintering of high dose controlled release pharmaceutical dosage form, which contains almost exclusively drug substance - just crystalline paracetamol as a model drug substance and small amount of dye were used. Comprehensive printlet characterization, that included pore space analysis, drug release and subsequent dissolution modeling as well as exploratory analysis, revealed various degrees of freedom for tuning its functional properties i.e. dissolution performance. Two degrees of freedom were found substantial for the proposed approach: (1) the macro structure shaping in terms of active surface to volume ratio; (2) microstructure shaping in terms of pore space structure. The latter was found to have a great potential and can be modified by the manufacturing parameters, e.g. hatch spacing. The simplicity of the preparation and flexibility to control the dissolution performance of the pharmaceutical dosage are the advantages of the proposed approach.

Automated summary

This paper presents a unique approach to 3D printing by Selective Laser Sintering of high dose controlled release pharmaceutical dosage form, using mainly crystalline paracetamol as a model drug substance. The study found that the functional properties, particularly dissolution performance, can be tuned by adjusting the active surface to volume ratio and pore space structure of the printlet. The flexibility and simplicity of preparation are highlighted as advantages of this approach.